Tower Research Capital LLC (Trc) Albireo Pharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$18.01 - $23.78 $283,261 - $374,011	-15,728 Reduced 94.0%	1,004 $22,000
Q3 2022 Nov 10, 2022	BUY	$16.32 - $26.37 $231,727 - $374,427	14,199 Added 560.56%	16,732 $324,000
Q2 2022 Aug 15, 2022	BUY	$18.54 - $37.29 $19,949 - $40,124	1,076 Added 73.85%	2,533 $50,000
Q1 2022 May 12, 2022	SELL	$23.94 - $33.74 $21,785 - $30,703	-910 Reduced 38.45%	1,457 $43,000
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $30,810 - $45,495	-1,454 Reduced 38.05%	2,367 $55,000
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $69,877 - $91,892	2,554 Added 201.58%	3,821 $119,000
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $22,542 - $28,758	-780 Reduced 38.1%	1,267 $45,000
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $15,310 - $20,482	-478 Reduced 18.93%	2,047 $72,000
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $357,858 - $478,052	-11,339 Reduced 81.79%	2,525 $94,000
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $260,214 - $466,905	11,221 Added 424.56%	13,864 $463,000
Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $39,169 - $79,078	2,643 New	2,643 $70,000
Q4 2019 Feb 07, 2020	SELL	$16.92 - $28.96 $10,507 - $17,984	-621 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$20.0 - $31.88 $12,420 - $19,797	621 New	621 $12,000
Q2 2019 Aug 13, 2019	SELL	$30.67 - $37.86 $7,115 - $8,783	-232 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$22.22 - $32.21 $9,821 - $14,236	-442 Reduced 65.58%	232 $7,000
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $13,961 - $21,756	668 Added 11133.33%	674 $16,000
Q3 2018 Nov 13, 2018	SELL	$29.29 - $36.87 $27,796 - $34,989	-949 Reduced 99.37%	6 $0
Q2 2018 Aug 15, 2018	BUY	$28.9 - $37.31 $27,599 - $35,631	955 New	955 $34,000
Q1 2018 May 15, 2018	SELL	$26.78 - $39.35 $1,740 - $2,557	-65 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$21.56 - $28.14 $495 - $647	23 Added 54.76%	65 $2,000
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $858 - $1,077	42	42 $1,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account